Lung Cancer Mortality Risk Predicted by Blood Test
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read More
Search Results for: lung cancer
Breath Biopsy Test for Lung Cancer in Development
Owlstone Medical announced new data on the development of a breath biopsy screening test for the early detection of lung cancer.
Read More
New Lung Cancer Classification Model Shows Promise
The first-generation lung cancer classification model based on gene expression data is already available for use within Qlucore Insights.
Read More
Exai Bio Presents New Non-Small Cell Lung Cancer Early Detection Data
New data demonstrates Exai Bio’s novel RNA- and AI-based platform detected non-small cell lung cancer with high accuracy.
Read More
Median Technologies Completes FDA Q-Submission Phase for Lung Cancer Screening Software
The Q-submission phase is a regulatory step which allows regular and in-depth discussions with the FDA on key topics.
Read More